A day after Pacira Pharmaceuticals Inc. priced its $42 million initial public offering (IPO), two more life sciences companies followed: Oncology firm Endocyte Inc. priced 12.5 million shares at $6 each to raise $75 million while diagnostics company BG Medicine Inc. set a $7 price for 5 million shares to bring in $35 million. (See BioWorld Today, Feb. 4, 2011.)